Brainstorm Cell Therapeutics (BCLI) Announces Feedback from FDA Type-C Meeting on Future NurOwn® Manufacturing Plan
Go back to Brainstorm Cell Therapeutics (BCLI) Announces Feedback from FDA Type-C Meeting on Future NurOwn® Manufacturing Plan| Brainstorm Cell Therapeutics, Inc. (NASDAQ: BCLI) | Delayed: 0.53 -0.02 (3.64%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.55 | 52 Week High | $3.87 | |||
| Open | $0.55 | 52 Week Low | $1.90 | |||
| Day High | $0.56 | P/E | N/A | |||
| Day Low | $0.52 | EPS | $-0.03 | |||
| Volume | 274,870 | |||||
